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Abstract
Background: The roots of Sophora flavescens (Leguminosae) have been used in East Asian countries as an herbal
medicine and a food ingredient for thousands of years. The aim of the present study was to investigate the effects
of S. flavescens fermentation on endotoxin-induced uveitis (EIU) in rats.
Methods: EIU was induced in rats via a footpad injection of lipopolysaccharide (LPS). Immediately after the LPS
inoculation, fermented and non-fermented extracts of S. flavescens (FSE and NFSE, respectively) were administered
orally, and the aqueous humor was collected from both eyes 24 hours later. The anti-inflammatory effects of FSE
and NFSE were examined in terms of regulation of nuclear factor kappa B (NF-B) activation and the expression of
interleukin-1b (IL-1b), tumor necrosis factor-a (TNF-a), inducible nitric oxide synthase (iNOS), intercellular cell
adhesion molecule (ICAM)-1, and cyclooxygenase-2 (COX-2). The regulation of maleic dialdehyde (MDA) levels and
polymorphonuclear cell (PMN) infiltration by FSE and NFSE were also examined.
Results: Treatment with FSE significantly inhibited LPS-induced increases in IL-1b and TNF-a production and the
expression of iNOS, ICAM-1 and COX-2. Moreover, FSE suppressed LPS-induced NF-B activation, and reduced both
MDA levels and infiltration by PMN.
Conclusion: These results indicate that solid state fermentation may enhance the anti-inflammatory effects of S.
flavescens.
Background
Inflammation plays an important role in a wide variety
of chronic human diseases including cardiovascular dis-
eases and cancer. Although various chemical regimens
have been used to treat inflammation, efficacy can be
u n s a t i s f a c t o r ya n dm a ye n c ounter the problem of drug
resistance. To improve treatments based on anti-inflam-
matory chemicals, novel therapeutic strategies may be
developed from medical plants used in Chinese Tradi-
tional Medicine. Of the huge array of candidates avail-
able, we chose to investigate Sophora flavescens
(Leguminosae) because of its potential health promoting
properties; it is anti-inflammatory, an anti-asthmatic, an
anthelmintic, and a free radical scavenger, and it has
antimicrobial activities and improves mental health
[1-5].
The roots of S. flavescens (Leguminosae) have been
traditionally used in East Asian countries as an herbal
medicine and food ingredient for thousands of years. S.
flavescens contains alkaloids, triterpenoids, and flavo-
noids, which are known to have various biological activ-
ities [6]. However, different processing methods (such as
fermentation) change the properties of this material.
Therefore, the aim of the present study was to develop
a solid state fermentation (SSF) protocol for S. flavescens
and to investigate whether this method led to an
increase in its anti-inflammatory effects.
SSF is a fermentation process conducted on a solid
support, which has low moisture content and occurs in
a non-septic and natural state [7]. SSF is a cutting-edge,
clean technology with great potential for use in the pro-
duction or extraction of biologically active compounds
from natural sources. Some studies show that SSF
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any medium, provided the original work is properly cited.changes the properties of the plant materials; therefore,
we compared the anti-inflammatory properties of fer-
mented and non-fermented roots.
To better elucidate the anti-inflammatory effects of
the fermented and non-fermented extracts of S. flaves-
cens (FSE and NFSE, respectively), a rat model of endo-
toxin-induced uveitis (EIU) was created by inducing
acute anterior segment intraocular inflammation via an
injection of lipopolysaccharide (LPS) [8,9]. In this
model, LPS directly stimulates the vascular endothelium,
macrophages, and other inflammatory cells, which
release factors such as nitric oxide [10,11], cytokines
(including tumor necrosis factor (TNF-a)) [12], and
eicosanoid mediators [13]. The levels of these molecules
were measured in FSE- or NFSE-treated rat eyes. The
results showed that SSF enhances the anti-inflammatory
effects of S. flavescens in a rat model of EIU.
Methods
Plant material
The roots of S. flavescens were collected from Shandong
Province, China, in October 2009. A fine powder for use
in the extraction study was prepared by milling dry S.
flavescens with a mechanical grinder and sieving through
a 20-mesh metal sieve.
Microorganisms and fermentation
The seeds of Coprinus comatus were purchased from
the Agricultural Culture Collection of China. First, the
seeds were grown at 28°C for 5 days on PDA slants
(1,000 mL 20% potato extract liquid + 20.0 g dextrose +
20.0 g agar) and then maintained at 4°C in a refrigera-
tor. Five to six pieces of C. comatus mycelia were trans-
ferred from a slant into 250 mL Erlenmeyer flasks
containing 100 mL liquid medium (20% potato extract
liquid + 2.0% dextrose + 0.1% KH2PO4 + 0.05%
MgSO2). The culture was incubated at 27°C on a rotary
shaker at 180 rpm for 7 days [14,15].
Ground S. flavescens (50 g) was autoclaved in Erlen-
meyer flasks (500 mL) for 20 min at 121°C. After cool-
ing, the flasks were inoculated with 15 mL of inoculum
and incubated at 27°C for 30 days.
FSE and NFSE preparation
Fermented and non-fermented S. flavescens was dried at
room temperature (24.2 ± 1.0°C), and refluxed and
extracted three times for 4 h in boiling water at a dried
material to solvent ratio of 1:6 (w/v). The supernatant
was collected by filtration, and the solvent was evapo-
rated under reduced pressure and lyophilized.
Animals
Healthy male adult Wistar rats (2 months old and
weighing 225 ± 25 g) were used in the study. The study
was approved by Shandong University’s ethics commit-
tee, and all procedures complied with the guidance set
out in the Guidelines for Caring for Experimental Ani-
mals published by the Ministry of Science and Technol-
ogy of the People’s Republic of China. Every care was
taken to minimize discomfort, distress, and pain.
EIU was induced by a footpad injection of 200 μgL P S
(from Escherichia coli, Nanjing Duly Biotech Co., Ltd.,
China; 100 μg per footpad) diluted in 0.1 mL phos-
phate-buffered saline (pH 7.4).
Thirty EIU rats were selected and divided three equal
groups: an endotoxin-treated group, an FSE-treated
group, and an NFSE-treated group. The three groups
were given oral saline, FSE (75 mg/kg/d) or NFSE (75
mg/kg/d), respectively. Ten normal control rats were
given saline only. Twenty-four hours later, the rats were
sacrificed and the aqueous humor (15-20 μL/rat) was
collected from both eyes for measurement of inflamma-
tory cells and inflammatory mediators.
Measurement of maleic dialdehyde (MDA)
MDA, a reliable marker for lipid peroxidation, was mea-
sured using a thiobarbituric acid assay (Nanjing Jian-
cheng Bioengineering Institute) according to the
manufacturer’s instructions. The total protein content of
the samples was measured using a Coomassie Blue assay
(Nanjing Jiancheng Bioengineering Institute) and the
MDA content (nmol/mg protein) calculated using the
following formula: absorbance of sample tube/absor-
bance of standard tube × 2.5.
Measurement of PMN infiltration
Myeloperoxidase (MPO) activity was measured to assess
the extent of polymorphonuclear cell (PMN) infiltration
into the eyes using a commercial assay kit (Nanjing Jian-
cheng Bioengineering Co., Ltd., China).
Measurement of IL-1b and TNF-a
The concentration of interleukin-1b (IL-1b) and TNF-a
in the aqueous humor was determined using a commer-
cial ELISA kit (Shanghai Jinma Biological Technology
Inc., China) according to the manufacturer’s
instructions.
Measurement of NF-B activation
Nuclear factor kappa B (NF-B) activation in the eyes
was determined using an ELISA kit (Shanghai Jinma
Biological Technology Inc., China) according to the
manufacturer’s instructions. This kit specifically detects
the p50 sub-unit of NF-B.
Measurement of ICAM-1, iNOS, and COX-2 levels
Expression of intercellular cell adhesion molecule
(ICAM)-1, inducible nitric oxide synthase (iNOS), and
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mercially available immunohistochemistry kit (Hengda-
baisheng Biotechnology, Beijing, China) according to the
manufacturer’s instructions.
Statistical analysis
Data were expressed as the mean ± S.E.M. and the
results analyzed by ANOVA followed by Dunnett’st
test. A p value of < 0.05 was considered significant.
Results and Discussion
S. flavescens has many pharmacological properties,
including anti-inflammatory activity. Therefore, the aim
o ft h ep r e s e n ts t u d yw a st oi n v e s t i g a t ew h e t h e rS S F
enhanced the anti-inflammatory effects of S. flavescens.
During SSF, the microorganisms associated with fer-
mentation degrade the plant cell walls, enabling the
release of biologically active compounds during the next
extraction stage. This results in high concentrations of
biologically active compounds, which may enhance the
anti-inflammatory effects of S. flavescens.
Peroxidation damage plays an important role in the
progression of LPS-induced injury; therefore, the anti-
oxidant effects of FSE were investigated by measuring
MDA levels. The control animals showed low MDA
levels; however, the MDA levels in the saline group
were significantly higher (p < 0.05). As shown in Figure
1, MDA level in the FSE and NFSE groups were signifi-
cantly lower than those in the saline group (p < 0.01
and p < 0.05, respectively).
PMN infiltration is initiated by inflammatory media-
tors. In addition to direct neuronal damage, PMNs con-
tribute to secondary injury by causing microvessel
occlusion and releasing oxygen radicals, cytolytic
proteases, and proinflammatory cytokines, which may
injure the endothelium [16,17]. Chopp et al. reported
that a reduction in the number of PMNs reduced post-
ischemic tissue damage in the heart, intestine, lung, and
liver [18]. The present study was undertaken to deter-
mine whether FSE reduces the number of PMNs in the
aqueous humor. The activity of MPO was measured as
an indicator of PMN migration. The results showed that
MPO activity was relatively low in the control group,
but significantly increased in the saline group. Treat-
ment with FSE significantly reduced EIU-induced MPO
a c t i v i t yc o m p a r e dw i t ht h a ti nt h es a l i n eg r o u p( p<
0.01, Table 1). NFSE treatment also reduced LPS-
induced MPO activity; however, this was not statistically
significant.
Cytokines are small glycoproteins produced in
response to an antigen, and were originally described as
mediators for regulating the innate and adaptive
immune responses. Thus, cytokine expression is upregu-
lated in many diseases. Of these inflammatory media-
tors, IL-1b and TNF-a are of particular importance
b e c a u s et h e yp l a yam a j o rr o l ei nc o o r d i n a t i n gt h e
mechanisms that regulate pro-inflammatory responses
[19]. Figure 2 shows that IL-1b levels were significantly
increased in the aqueous humor of EIU rats. Treatment
with both NFSE and FSE resulted in a marked decrease
in IL-1b levels compared with those in the saline group
(p < 0.05 and p < 0.01, respectively). In addition, the
levels of TNF-a were significantly increased after endo-
toxin injection (Figure 3). FSE suppressed EIU-induced
TNF-a production (p < 0.05); however, this was not the
case in the NFSE-treated group.
NF-B comprises a family of transcription factors that
regulate the expression of pro-inflammatory mediators
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Figure 1 Effects of FSE and NFSE on MDA levels. Values represent the mean ± SEM. *p < 0.05 vs. saline group; **p < 0.01 vs. saline group.
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increases in IL-1b and TNF-a mRNA levels [21]. There-
fore, we hypothesized that FSE may potentially show
beneficial effects by decreasing the expression of NF-B.
A ss h o w ni nF i g u r e4 ,N F - B expression in the saline
group was significantly higher than that in the control
group (p < 0.01), and FSE treatment significantly sup-
pressed EIU-induced NF-B expression. This is consis-
tent with the results presented in Figure 2 and 3. Taken
together, these results suggest that the inhibitory effects
of FSE on expression of the NF-Bp 5 0s u b u n i ta r e
associated with reduced concentrations of IL-1b and
TNF-a in EIU rats.
As shown in Table 2, EIU rats expressed typical mar-
kers of inflammation, including upregulation of adhesion
molecules and production of pro-oxidative enzymes
(COX-2 and iNOS). The adhesion molecule, ICAM-1,
has been extensively investigated. The expression of
ICAM-1 in the EIU group was significantly higher than
that in the control group. NFSE and FSE treatment
markedly decreased the level of ICAM-1 expression
compared with that in the saline group (p < 0.05 and p
< 0.01, respectively).
Nitric oxide (NO) production, induced by bacterial
LPS or cytokines, plays an important role in endotoxe-
mia and inflammatory conditions [22], and selective
inhibitors of iNOS inhibit the development of EIU [23].
Therefore, we wondered whether FSE, which inhibits
NO production by inhibiting iNOS expression, had any
positive therapeutic effects on inflammation. The results
showed that FSE treatment inhibited the development of
EIU and suppressed LPS-induced iNOS expression.
Treatment with NFSE also reduced iNOS expression;
however, this was not statistically significant.
NO also activates COX enzymes leading to a marked
increase in PGE2 production [24]. COX-2 is primarily
responsible for increased PGE2 production during
inflammation, and PGE2 is generally considered to be a
pro-inflammatory agent [25,26]. As shown in Table 2,
the expression of COX-2 in the EIU group was signifi-
cantly increased compared with that in the control
group. FSE and NFSE treatment significantly decreased
Table 1 Effects of FSE and NFSE on MPO activity
Groups (U/g
-1)
Control group 0.99 ± 0.21*
Saline group 2.08 ± 0.22
FSE group 1.11 ± 0.15*
NFSE group 1.87 ± 0.20
Values represent the mean ± SEM. *p < 0.05 vs. saline group.
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Figure 2 Effects of FSE and NFSE on IL-1b concentration. Values
represent the mean ± SEM. *p < 0.05 vs. saline group; **p < 0.01
vs. saline group.
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Figure 3 Effects of FSE and NFSE on TNF-a concentration.
Values represent the mean ± SEM. *p < 0.05 vs. saline group.
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Figure 4 Effects of FSE and NFSE on NF-B activation.V a l u e s
represent the mean ± SEM. *p < 0.05 vs. saline group.
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and p < 0.05, respectively).
Conclusion
The results of the present study clearly demonstrate the
protective effects of FSE against EIU in rats. FSE treat-
ment inhibited the production of EIU-induced inflam-
matory cytokines (IL-1b and TNF-a), decreased the
levels of inflammation-related markers (MPO and
ICAM-1), decreased the expression of pro-oxidative
enzymes such as COX-2 and iNOS, and down-regulated
the expression of NF-B. Although both NFSE and FSE
showed protective effects against EIU in rats, there was
a significant difference between them. Taken together,
the results of the present study show that SSF enhances
the anti-inflammatory effects of S. flavescens.
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